Physician profile
Kumar Ennamuri
NPI 1396783056
$563.76
in general payments reported to CMS, 2019-2025
8 companies · $16.47 in 2025
The $16.47 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.70 · 2020: $13.27 · 2021: $12.94 · 2022: $19.63 · 2024: $444 · 2025: $16.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $400 · Food and Beverage: $60.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $400.00 |
| Food and Beverage | $60.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $400.00 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Sunovion Pharmaceuticals INC. | $38.32 | 2019 | |
| Abbott Laboratories | $30.46 | 2024 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals Lp | $26.21 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $19.63 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.38 | 2019 | |
| Exact Sciences Corporation | $16.47 | 2025 | Cologuard Collection Kit |
| Amgen INC. | $13.29 | 2024 | Otezla, Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kumar Ennamuri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.